1. Home
  2. /
  3. Private Label
Science with commercial momentum

License the science.
Build the brand.

CosTinia provides the proprietary biological engine behind premium companion-animal products—and the support to move from concept to shelf.

Discuss your concept Review the evidence
Unbranded sample containers, formulation materials, and a precision scale arranged on a development worktable
Product-development contextConceptual editorial visualization; not a Costinia product or facility
Follow the partnership
01
02 / 06Discover & formulate

Begin with the job
the product must do.

Together we define the target species, intended benefit, CFU target, delivery format, product concept, and the clinical story behind it.

Your brief
Species, need, format, market, price position, timeline
Our contribution
Strain fit, feasibility, formulation direction, evidence route
Decision
A development brief with scope and technical assumptions
03 / 06Test & validate

Make the product
earn its shelf life.

Pilot batches are tested for stability, compatibility, and shelf life. Documentation follows the formulation through every stage.

  1. 01
    Compatibility

    Confirm strain performance in the intended matrix and delivery format.

  2. 02
    Stability

    Track viability and CFU retention under defined conditions.

  3. 03
    Claims route

    Align substantiation and regulatory documentation with the launch market.

Prepared glass sample vessels arranged in a laboratory rack beside analytical equipment
Stability-testing contextConceptual editorial visualization; not study data or a Costinia laboratory
04 / 06Produce & launch

One quality logic,
from pilot to scale.

Move through EU GMP-aligned manufacture with lot traceability, from clinical pilot to multi-ton supply.

Production
EU alignedGMP-aligned manufacturing pathway
Traceability
Lot-leveldocumentation across commercial supply
Launch support
Claims reviewplus sales-team training
Continuity
Ongoingpost-market documentation updates
A generic automated production line filling unbranded containers
Scale contextMina Rad via Unsplash; not a Costinia or partner facility
05 / 06Application space

Six routes into
companion-animal care.

Proprietary strains can be deployed across product formats and target indications for dogs and cats.

  1. 01
    Gastrointestinal health

    Sensitive digestion, stool quality, and recovery after antibiotic therapy.

  2. 02
    Dental & oral care

    Chews, water additives, and dental diets targeting plaque and malodor.

  3. 03
    Skin & coat

    Gut–skin axis support for atopic, sensitive, or seasonally reactive skin.

  4. 04
    Immune function

    Daily support for young, senior, and high-stress animals.

  5. 05
    Senior & wellness

    Mobility, cognition, and long-term microbiome resilience.

  6. 06
    Performance & recovery

    Microbiome support for working, sporting, and high-activity dogs.

06 / 06Commercial models

Structure the relationship
around the ambition.

Flexible structures match your market, application, and exclusivity requirements.

Start a private-label conversation
  1. 01
    Exclusive license

    Single-partner rights for a defined species, application, or territory, with technical and marketing support.

  2. 02
    Non-exclusive supply

    A standard supply agreement with strain-library access for brands entering or expanding the category.

  3. 03
    Co-development

    Joint R&D for novel applications or species, structured around shared investment and IP.